ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GANX Gain Therapeutics Inc

2.63
-0.06 (-2.23%)
After Hours
Last Updated: 21:30:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 45k95k0055k000
Operating Income -3.29M-5.18M-4.75M-4.56M-5.23M-7.73M-4.89M-4.41M
Pre Tax Income -3.27M-5.08M-4.55M-4.6M-5.12M-7.66M-4.7M-4.71M
Net Income -3.27M-5.09M-4.56M-4.68M-5.14M-7.69M-4.72M-4.57M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -3.29M-5.18M-4.75M-4.56M-5.23M-7.73M-4.89M-4.41M
EBITDA -3.28M-5.14M-4.75M-4.54M-5.21M-7.71M-4.86M-4.38M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 41k29k196k140k55k
Operating Income -2.1M-3.48M-13.8M-17.78M-22.25M
Pre Tax Income -2.19M-3.57M-13.86M-17.5M-22.19M
Net Income -2.19M-3.58M-13.86M-17.59M-22.11M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -0.975-0.889-1.166-1.48-1.713
EBIT -2.1M-3.48M-13.8M-17.78M-22.25M
EBITDA -2.1M-3.47M-13.78M-17.71M-22.17M